Intelligent Hypertension Intervention Study

Shanghai Tong Ren Hospital320 enrolled

Overview

To explore whether the application of intelligent hypertension management system can effectively reduce blood pressure in hypertensive patients. A total of 320 eligible subjects will be recruited and randomization to two groups. The standard care group (n=160) will receive conventional hypertension treatment with baseline data collected.Wearable blood pressure monitoring device management group (intervention group, n=160) will receive blood pressure monitoring remotely everyday and antihypertension medication treatment. Primary outcome is Net change in systolic blood pressure from baseline to 3 months follow-up. Secondary outcomes include Net change in diastolic blood pressure hypertension control ratio (BP \< 140/90 mmHg)

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

320

Conditions

To Explore Whether the Application of Intelligent Hypertension Management System Can Effectively Reduce Blood Pressure in Hypertensive Patients

Interventions

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Aged more than 18 years old, less than or equal to 75 years old. 2. Hypertensive patients (systolic/diastolic blood pressure ≥140/90 mmHg at two separate screening/baseline visits) 3. Patients or guardians can skillfully use devices such as smartphones and electronic sphygmomanometers 4. Voluntarily joined and signed the informed consent Exclusion Criteria: 1. Pregnant women or women planning to become pregnant within the next year; 2. Patients with secondary hypertension 3. Patients with life expectancy less than 1 year 4. Severe hepatic and renal insufficiency (ALT \> 5 times ULA, eGFR \< 15ml/min/1.73mm2) 5. Known active malignancy disease 6. The researcher believes that patients who are not suitable to participate in this study

Locations (3)

Shanghai tongren hospital

Shanghai, Shanghai Municipality, China

Shanghai Fifth Rehabilitation Hospital

Shanghai, China

Songjiang hospital, Shanghai jiaotong University, School of medicine

Shanghai, China

Outcomes

Primary Outcomes

Net change in systolic blood pressure from baseline to 3 months follow-up

Time frame: one and three months after study

Secondary Outcomes

Net change in diastolic blood pressure

Time frame: one and three months after study

Hypertension control ratio (BP < 140/90 mmHg)

Time frame: one and three months after study